With New Technology, Researchers Engineer A Plant For Every Purpose

Purpose Author: KATHRYN S. BROWN SIDEBAR: Plant Science Resource Plant biologists are more than just highly educated green thumbs. Armed with new technology, researchers are engineering plants to tackle some of society's nettlesome problems. And plant biologists point out that transgenic studies today could yield vegetation able to deliver vaccines, clean the environment, or manufacture chemicals tomorrow. MAKING HAY: Wisconsin plan physiologist Robert Goodman notes that industry funds the

Written byKathryn Brown
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Purpose Author: KATHRYN S. BROWN

SIDEBAR: Plant Science Resource

Plant biologists are more than just highly educated green thumbs. Armed with new technology, researchers are engineering plants to tackle some of society's nettlesome problems. And plant biologists point out that transgenic studies today could yield vegetation able to deliver vaccines, clean the environment, or manufacture chemicals tomorrow.

Robert Goodman MAKING HAY: Wisconsin plan physiologist Robert Goodman notes that industry funds the "bold ideas" while federal funding is "sparse". "Plants are very efficient producers," says Chris Somerville, an investigator with the Carnegie Institution of Washington's plant lab in Stanford, Calif. "That means they can be a cheap, renewable resource for hundreds of things." Somerville, for example, has engineered plants to produce plastic and the precursor to nylon.

The driving force behind today's plant-for-every-purpose research is an ability to identify and engineer genes, in both plants and their invading bacteria.

ADDED POWER: Clarence Ryan ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies